Latest News

Tech Transfer Think Tank: 4T - Meeting - 22 May 20...

This year conference will be on May 22 at Kilometrorosso, Via Stezzano 87, Bergamo, Italy.

IFIB 2015 - 5th Annual conference, 24-25 September...

The IFIB (Italian Forum for Industrial Biotechnology and Bioeconomy) annual conference and partnering event will be held in Lodi on 24-25 September 20...

Intesa Sanpaolo Biotech and Healthcare Investment...

The Biotech and Healthcare-Medical Device start-up arena meeting will be held on 21 and 22 April 2015 in Milano. 

Sofinnova Renewable Chemistry Start-up Award

Sofinnova Start-up Award recognises the most promising renewable chemistry start-up The Top 5 companies will be selected by popular vote online and th...

Please reload

1/3

An European Medicines Agency submission is not an easy task. It is a time-consuming, need experienced people, planning capabilities and strong project management. We offer our support  in order reduce time, improve quality of submission and consequently chance of success. 

 Without a strategy you are not able to identify challanges, allocate resources, define timeline and respect  dedlines.          

 A good Regulatory strategy oversee the whole development process, helping you to save time and money, improving chance of success. 

 

Products and technologies available for license or sale

Device for monitoring the risks for sudden infant...

March 27, 2014

A portable monitoring device (101) performs the monitoring of the short term, mid term and long term risks of Sudden Infant Death Syndrome (SIDS)

Heavy metals immobilization in zeolites synthesize...

March 27, 2014

The process of zeolite synthesis from fly ash at low temperature using seawater can be successfully apply directly in polluted soil thus permitting th...

Please reload

We offer a full range of  quality systems and external activities review and audits. Our audits are conducted by experienced professionals who produce audit reports with the highest levels of accuracy and consistency in respect of timelines. We are priced competitively and we are qucik in activation.

 

We could evaluate your technology or idea and provide you a report with an in dept analysis of:

1) The technical merits and challenges of your invention;

2) The Intellectual Property rights that you may have available

3) The commercial potential and pathways available to commercialise your invention

Focus on Biosimilars

Regulatory service for development and approval of biosimilars in the EU

Advice on regulatory specific strategy for EU biosimilars. 

Please reload

* External links open from the window